Egyptian (OMX) Pharma Industry Analysis
UpdatedJan 27, 2023
DataAggregated Company Financials
Companies11
- 7D0.7%
- 3M18.9%
- 1Y12.4%
- YTD-1.7%
In the last week, the Pharma industry is flat overall, with Kahira Pharmaceuticals & Chemical Industries standing out by going down 9.2%. The past year has been better, since the industry has gained 12% in that time. As for the next few years, earnings are expected to grow by 10% per annum.
Industry Valuation and Performance
Has the Egyptian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 27 Jan 2023 | ج.م15.2b | ج.م15.6b | ج.م2.3b | 5.4x | 6.7x | 1x |
| Sun, 25 Dec 2022 | ج.م15.0b | ج.م15.6b | ج.م2.3b | 5.3x | 6.6x | 1x |
| Tue, 22 Nov 2022 | ج.م13.3b | ج.م15.1b | ج.م2.2b | 4.4x | 6.1x | 0.9x |
| Thu, 20 Oct 2022 | ج.م12.5b | ج.م15.1b | ج.م2.2b | 4.7x | 5.8x | 0.8x |
| Sat, 17 Sep 2022 | ج.م12.9b | ج.م14.3b | ج.م2.0b | 6.1x | 6.3x | 0.9x |
| Mon, 15 Aug 2022 | ج.م12.7b | ج.م14.2b | ج.م2.0b | 5.5x | 6.5x | 0.9x |
| Wed, 13 Jul 2022 | ج.م11.8b | ج.م14.1b | ج.م1.9b | 5.6x | 6.1x | 0.8x |
| Fri, 10 Jun 2022 | ج.م12.2b | ج.م13.8b | ج.م1.9b | 5.9x | 6.5x | 0.9x |
| Sun, 08 May 2022 | ج.م12.3b | ج.م11.9b | ج.م1.7b | 5.7x | 7.4x | 1x |
| Tue, 05 Apr 2022 | ج.م12.8b | ج.م11.7b | ج.م1.7b | 5.5x | 7.7x | 1.1x |
| Thu, 03 Mar 2022 | ج.م13.0b | ج.م13.5b | ج.م1.9b | 6.5x | 7x | 1x |
| Sat, 29 Jan 2022 | ج.م13.5b | ج.م13.3b | ج.م1.8b | 6.3x | 7.4x | 1x |
| Mon, 27 Dec 2021 | ج.م13.4b | ج.م13.3b | ج.م1.8b | 5.4x | 7.4x | 1x |
| Wed, 24 Nov 2021 | ج.م12.0b | ج.م13.2b | ج.م1.8b | 5.9x | 6.7x | 0.9x |
| Fri, 22 Oct 2021 | ج.م12.2b | ج.م12.9b | ج.م1.8b | 5.9x | 6.9x | 0.9x |
| Sun, 19 Sep 2021 | ج.م13.6b | ج.م13.0b | ج.م1.8b | 5.1x | 7.6x | 1x |
| Tue, 17 Aug 2021 | ج.م13.7b | ج.م13.0b | ج.م1.8b | 5.2x | 7.6x | 1.1x |
| Tue, 01 Jun 2021 | ج.م12.3b | ج.م12.6b | ج.م1.7b | 5.3x | 7.4x | 1x |
| Fri, 05 Mar 2021 | ج.م14.5b | ج.م12.2b | ج.م1.6b | 7.4x | 9x | 1.2x |
| Mon, 07 Dec 2020 | ج.م13.2b | ج.م12.1b | ج.م1.6b | 6.4x | 8.2x | 1.1x |
| Thu, 10 Sep 2020 | ج.م12.7b | ج.م12.0b | ج.م1.6b | 5.7x | 8x | 1.1x |
| Wed, 03 Jun 2020 | ج.م11.7b | ج.م11.9b | ج.م1.5b | 5.2x | 7.7x | 1x |
| Sat, 07 Mar 2020 | ج.م15.2b | ج.م11.8b | ج.م1.4b | 7.3x | 10.7x | 1.3x |
Price to Earnings Ratio
10.5x
Current Industry PE
- Investors are pessimistic on the Egyptian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 6.7x which is lower than its 3-year average PE of 7.5x.
- The industry is trading close to its 3-year average PS ratio of 1.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 9.7% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Egyptian Pharma compare with similar industries?
| EG Market | 2.78% | |
| Healthcare | 1.16% | |
| Pharma | 0.66% | |
| Pharma | 0.66% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E | ج.م2.81 | 3.7% +ج.م97.4m | 23.2% | PE10.8x | |
| BIOC GlaxoSmithKlineE | ج.م35.02 | 1.4% +ج.م41.8m | 28.3% | PE14x | |
| AXPH Alexandria For Pharmaceuticals & Chemical Industries | ج.م139.97 | 2.3% +ج.م15.8m | 29.5% | PE5.4x | |
| NIPH Nile for Pharmaceuticals and Chemical Industries | ج.م36.07 | 3.3% +ج.م11.7m | 14.2% | PE4.1x | |
| ADCI Arab Drug | ج.م57.57 | 1.0% +ج.م3.4m | 9.5% | PE3.7x |